Literature DB >> 25897818

Inhibiting the VIM-2 Metallo-β-Lactamase by Graphene Oxide and Carbon Nanotubes.

Po-Jung Jimmy Huang1, Rachel Pautler1, Jenitta Shanmugaraj1, Geneviève Labbé1, Juewen Liu1.   

Abstract

Metallo-β-lactamases (MBLs) degrade a broad spectrum of antibiotics including the latest carbapenems. So far, limited success has been achieved in developing its inhibitors using small organic molecules. VIM-2 is one of the most studied and important MBLs. In this work, we screened 10 nanomaterials, covering a diverse range of surface properties including charge, hydrophobicity, and specific chemical bonding. Among these, graphene oxide and carbon nanotubes are the most potent inhibitors, while most other materials do not show much inhibition effect. The inhibition is noncompetitive and is attributed to the hydrophobic interaction with the enzyme. Adsorption of VIM-2 was further probed using protein displacement assays where it cannot displace or be displaced by bovine serum albumin (BSA). This information is useful for rational design inhibitors for MBLs and more specific inhibition might be achieved by further surface modifications on these nanocarbons.

Entities:  

Keywords:  adsorption; beta-lactamases; carbon nanotubes; graphene; inhibition; nanomaterials

Mesh:

Substances:

Year:  2015        PMID: 25897818     DOI: 10.1021/acsami.5b01954

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  3 in total

Review 1.  The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.

Authors:  Lin-Cheng Ju; Zishuo Cheng; Walter Fast; Robert A Bonomo; Michael W Crowder
Journal:  Trends Pharmacol Sci       Date:  2018-04-18       Impact factor: 14.819

Review 2.  Nanozymes as Enzyme Inhibitors.

Authors:  Yaling Huang; Jian Jiang; Yanqiu Wang; Jie Chen; Juqun Xi
Journal:  Int J Nanomedicine       Date:  2021-02-12

Review 3.  Biological interactions of carbon-based nanomaterials: From coronation to degradation.

Authors:  Kunal Bhattacharya; Sourav P Mukherjee; Audrey Gallud; Seth C Burkert; Silvia Bistarelli; Stefano Bellucci; Massimo Bottini; Alexander Star; Bengt Fadeel
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.